Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Prix Galien

- PMLiVE

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

Seven treatments for rare conditions have been selected for the final

- PMLiVE

Chiesi’s Holoclar wins UK Prix Galien orphan drug award

Novartis and Astellas also scoop prizes at the prestigious ceremony

- PMLiVE

AZ, BMS and Boehringer among UK Prix Galien finalists

They join Alexion, Chiesi, Janssen, Novartis, Otsuka and Takeda

- PMLiVE

Pharma could make more of its real world evidence

As the ‘cost versus value’ argument rears its head once again a new award could help pharma reaffirm the value of its medicines

- PMLiVE

UK Prix Galien opens for entries

Pharma R&D accolades will include a new real world evidence category

- PMLiVE

Novartis’ Bexsero triumphs at UK Prix Galien

The Awards also saw Janssen's Sirturo pick up the Orphan Drug prize

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links